本文選題：Rho激酶 + 微管�。� 參考：《南方醫(yī)科大學(xué)》2007年博士論文

【摘要】： 目的和意義: 神經(jīng)系統(tǒng)是由數(shù)千億神經(jīng)元通過突觸連接形成的一個既精確又復(fù)雜的神經(jīng)網(wǎng)絡(luò)。神經(jīng)元的發(fā)育過程中,經(jīng)歷了從分化、遷移、極化、定向生長到與靶細(xì)胞建立突觸聯(lián)系的動態(tài)過程。其突起末端的生長錐感受細(xì)胞外生長和導(dǎo)向信息,通過微管和微絲運(yùn)動使細(xì)胞形成樹突和軸突,并不斷生長、延伸或坍塌。細(xì)胞骨架系統(tǒng)不斷進(jìn)行重排是細(xì)胞突起生長、確定方向和遷移的關(guān)鍵。Rho家族的鳥苷三磷酸酶(Rho GTPases)是調(diào)節(jié)細(xì)胞骨架運(yùn)動的主要信號,細(xì)胞外生長和導(dǎo)向因子首先通過細(xì)胞膜上相應(yīng)的受體啟動Rho激酶,進(jìn)而通過坍塌反應(yīng)調(diào)節(jié)蛋白(CRMPs)影響細(xì)胞骨架的重排,如微管和微絲的聚合和解聚,而細(xì)胞骨架重排的結(jié)果是神經(jīng)元突起的生長、延伸或坍塌。神經(jīng)系統(tǒng)發(fā)育過程中賦予神經(jīng)元復(fù)雜的結(jié)構(gòu)及其它們形成的精確的神經(jīng)網(wǎng)絡(luò)構(gòu)成了神經(jīng)系統(tǒng)功能活動的基礎(chǔ),神經(jīng)元的發(fā)育不僅是從幼小到成熟的過程,也涉及損傷后的修復(fù)和再生過程,神經(jīng)組織損傷后突起的再生過程也被認(rèn)為是其發(fā)育過程的再現(xiàn)。探討Rho激酶通路對神經(jīng)元突起生長和微管重排的調(diào)節(jié)不僅有助于理解神經(jīng)損傷后的再生過程,也可以加深對神經(jīng)退行性病變發(fā)生的認(rèn)識,使我們有機(jī)會找到克服神經(jīng)組織再生和修復(fù)困難的新思路和干預(yù)靶點(diǎn)。 材料和方法: 實驗首先以發(fā)育不同階段的大鼠海馬為對象,提取總RNA,用RT-PCR的方法檢測大鼠海馬發(fā)育過程中突起生長導(dǎo)向因子GAP-43、Nogo-A、netrin-1、Sema 3A和Nrp-1 mRNA,以及Rho通路信號分子Rho A、Rac-1、CRMP-1和Tubβ3 mRNA的表達(dá)水平。進(jìn)而以原代大鼠海馬神經(jīng)元為對象,用Rho激酶促進(jìn)劑LPA和抑制劑Y27632干預(yù)海馬神經(jīng)元,LPA和Y27632的濃度200ng/ml,原子力顯微鏡觀察細(xì)胞突起的生長,并提取突起進(jìn)行定量;共聚焦顯微鏡觀察細(xì)胞微管的重排,并對粘附蛋白vinculin進(jìn)行亞細(xì)胞定位和分布特征進(jìn)行觀察。實驗進(jìn)一步構(gòu)建Rho激酶的下游信號CRMP-1的重組體,用非定向克隆技術(shù)構(gòu)建CRMP-1-phrGFPⅡ-N真核表達(dá)載體,陽性脂質(zhì)體法轉(zhuǎn)染NGF誘導(dǎo)分化的PC12細(xì)胞,觀察CRMP-1對細(xì)胞突起生長的影響。 結(jié)果: (1)大鼠海馬發(fā)育過程中生長導(dǎo)向因子和Rho通路信號分子mRNA的表達(dá) 大鼠海馬的發(fā)育過程中,生長因子GAP-43 mRNA胚胎和新生階段表達(dá)較多,幼年和成年階段表達(dá)較少(P＜0.05),老年階段表達(dá)仍維持較高水平;Nogo-A在胚胎階段表達(dá)較多,出生后和GAP-43相似,成年和老年階段處于高峰時期。導(dǎo)向因子netrin-1以胎鼠、新生鼠和成年鼠表達(dá)最強(qiáng),幼年和老年階段表達(dá)較少。Sema 3A隨著海馬發(fā)育逐漸降低,但其受體Nrp-1從幼年到老年表達(dá)逐漸增多。信號分子Rho-A和Rac-1的表達(dá)與Rho-A的表達(dá)有相似的變化規(guī)律,隨著海馬發(fā)育亦呈明顯的階段性,表達(dá)的高峰在胚胎、幼年和老年階段,而新生階段和成年階段處于相對低表達(dá)階段;Rac-1的表達(dá)量在海馬發(fā)育的各個階段均超過Rho-A的表達(dá)量。CRMP-1和tubulin的表達(dá)從胚胎到成年的各個階段與CRMP-1的表達(dá)具有相似的變化趨勢,以胎鼠、新生大鼠和幼年大鼠表達(dá)較多,但老年階段CRMP-1的表達(dá)較成年階段顯著升高(P＜0.05),而tubulin在老年階段停留在成年階段的水平。 (2)Rho激酶對大鼠海馬神經(jīng)元突起生長和微管重排的調(diào)節(jié) 原子力顯微鏡的觀察顯示,LPA處理組海馬神經(jīng)元突起的數(shù)量減少,一些突起僅見殘留的突起根部,一至三級突起的數(shù)目均減少(P＜0.05);LPA預(yù)處理后用Y27632干預(yù),雖然胞體的形態(tài)未見明顯的變化,但是一級突起的數(shù)目增多,呈輻射狀從胞體伸出,并伴有豐富的二級突起,一級和二級突起的數(shù)目與對照組相比增多(P＜0.05);提取突起的光密度測定顯示,LPA處理后的細(xì)胞較對照組降低(P＜0.05),LPA預(yù)處理后用Y27632干預(yù)組的細(xì)胞較LPA組升高(P＜0.05),與對照組無差異顯著。 共聚焦顯微鏡觀察顯示,海馬神經(jīng)元胞體、突起和生長錐均顯示清晰的微管,LPA干預(yù)組突起較短,而且突起遠(yuǎn)端的熒光較淺淡;胞體內(nèi)無清晰可見的絲網(wǎng)狀微管,取而代之的是不規(guī)則的微管,其粗細(xì)不均,排列不規(guī)整,失去原有的鳥巢樣外觀;突起內(nèi)微管的排列出現(xiàn)發(fā)辮樣改變,成束的微管之間出現(xiàn)較大的縫隙;生長錐失去原有的外貌,僅見突起細(xì)小的末端,無典型的生長錐,其中的微管大部分消失。LPA預(yù)處理后用Y27632干預(yù),胞體內(nèi)可見較清晰的絲網(wǎng)狀微管,這些微管粗細(xì)較均勻,除了圍繞胞核周圍分布的微管外,還可見末端游離的微管,伸入細(xì)胞的突起;突起內(nèi)的微管不甚規(guī)整,仍可見微管之間較大的空隙,但較LPA組排列規(guī)整;突起末端生長錐基本保持了原有的形態(tài),呈不典型的扇形突出,其中可見較清晰的微管,它們直行伸入生長錐或者彎曲走行,較長的微管伸入生長錐中心部位,短的微管位于生長錐的根部。vinculin蛋白散在分布于細(xì)胞膜上,LPA干預(yù)組細(xì)胞膜上亦可見綠色熒光點(diǎn)散在分布于細(xì)胞膜上;LPA處理后用Y27632干預(yù),細(xì)胞膜上分布較密集的綠色熒光,而且這些熒光點(diǎn)常聚集在一起,在細(xì)胞膜的周邊區(qū)域和突起的根部分布較密集,顯示vinculin蛋白在細(xì)胞膜的周邊聚集。 (3)CRMP-1-phrGFPⅡ-N真核表達(dá)載體的構(gòu)建及其對突起生長的調(diào)節(jié) 從大鼠海馬總RNA擴(kuò)增出的目的基因片斷為1800bp,符合設(shè)計片斷的大小;連接轉(zhuǎn)化后形成白色菌落,EcoRⅠ單酶切后的重組體出現(xiàn)1800bp大小的目的基因片斷和3000bp大小的克隆載體片斷,未經(jīng)酶切的重組體為4800bp。雙向測序結(jié)果顯示,CRMP-1目的基因片斷為1746bp,與genbank的序列比對顯示僅4位的堿基突變,不影響翻譯蛋白質(zhì),同源性為99.8%。與表達(dá)載體連接后,轉(zhuǎn)化細(xì)菌,挑取正向連接克隆,CRMP-1-phrGFPⅡ-N重組體電泳條帶位于6700bp處,酶切后顯示4900bp和1800bp兩個片斷。 50ng NGF誘導(dǎo)后,PCI2細(xì)胞突起延長,分化為神經(jīng)元樣細(xì)胞�？蛰d體轉(zhuǎn)染組的細(xì)胞顯示較強(qiáng)的綠色熒光,熒光分布于胞體和突起,細(xì)胞的突起較長。CRMP-1-phrGFPⅡ-N轉(zhuǎn)染組,其熒光與空載體轉(zhuǎn)染組分布相似,主要分布于胞體和突起,但細(xì)胞突起較短小,表達(dá)CRMP-1的細(xì)胞少見超過胞體直徑數(shù)倍的突起,個別較長的突起亦較空載體組短小。 結(jié)論: (1)在大鼠海馬的發(fā)育過程中,胚胎階段GAP-43和Nogo-A處于高表達(dá)狀態(tài),出生后回落,老年階段GAP-43仍維持較高水平,而Nogo-A在成年和老年均呈高表達(dá)狀態(tài),提示老年階段海馬神經(jīng)元仍具有較強(qiáng)的生長和再生能力,而抑制因子的高表達(dá)可能是再生困難的原因。 (2)生長導(dǎo)向因子netrin-1的表達(dá)貫穿胚胎、新生、幼年和成年階段,老年表達(dá)較低;而Sema 3A主要局限于胚胎和新生階段,但是其受體的表達(dá)在經(jīng)歷了新生階段的低表達(dá)后逐漸增多的過程。 (3)細(xì)胞內(nèi)Rho-A和Rac-1信號分子的發(fā)育雖然在各個階段均有較高的表達(dá),但具有明顯的階段性,新生和成年階段表達(dá)相對較低,胚胎、幼年和老年階段相對較高。 (4)微管蛋白的發(fā)育從胚胎到幼年呈逐漸下降的趨勢,成年和老年階段相對穩(wěn)定,CRMP-1的發(fā)育從胚胎到成年階段與微管的發(fā)育經(jīng)歷相似的變化,但是老年階段表達(dá)較高。 (5)激活Rho激酶通路可誘導(dǎo)神經(jīng)元突起坍塌,表現(xiàn)在各級突起數(shù)目的減少和長度的縮短,抑制Rho激酶通路可促使神經(jīng)元突起各級分支數(shù)目的增加以及突起的生長。Rho激酶不但通過調(diào)節(jié)微管重排參與突起的生長延長,還參與突起的分支形成,抑制Rho激酶的活性基本能逆轉(zhuǎn)LPA對突起生長的坍塌作用,但并不能完全逆轉(zhuǎn)LPA誘導(dǎo)的微管重排。 (6)擴(kuò)增了CRMP-1的cDNA,完成CRMP-1-PGEM-T Easy克隆載體和CRMP-1-phrGFPⅡ-N真核表達(dá)載體的構(gòu)建。 (7)轉(zhuǎn)染由NGF誘導(dǎo)分化的PC12細(xì)胞后,CRMP-1在細(xì)胞的胞體和突起表達(dá),導(dǎo)入CRMP-1外源基因的PC12細(xì)胞突起明顯縮短,顯示CRMP-1具有抑制突起生長和誘導(dǎo)其坍塌的作用。
[Abstract]:Purpose and significance:
A neural network is an accurate and complex neural network formed by a synapse of hundreds of billions of neurons through synapses. During the development of a neuron, a dynamic process from differentiation, migration, polarization, and directional growth to the target cells. Tube and microfilament movement causes cells to form dendrites and axons, growing, extending or collapsing. The cytoskeleton system constantly rearrangements is the growth of cell protuberances. The key.Rho family of.Rho (Rho GTPases) is the main signal to regulate cytoskeleton movement, and the extracellular growth and guiding factors are first passed. The corresponding receptor on the cell membrane starts the Rho kinase and then affects the rearrangement of the cytoskeleton through the collapse response regulating protein (CRMPs), such as the polymerization and disaggregation of microtubules and microfilaments, and the result of the rearrangement of the cytoskeleton is the growth, extension or collapse of the neurites. The complex structures and their shapes are given to the neurons in the process of the development of the nervous system. The exact neural network constitutes the basis of the functional activity of the nervous system. The development of neurons is not only from young to mature, but also in the process of repair and regeneration after injury. The process of regeneration of the neurites after the injury of the nerve tissue is also considered to be the reproduction of its development process. The growth of the neurites by the Rho kinase pathway and the growth of the neuron are discussed. The regulation of microtubule rearrangement not only helps to understand the process of regeneration after nerve injury, but also helps to deepen the understanding of the occurrence of neurodegenerative diseases, so that we have a chance to find new ideas and targets to overcome the difficulty of regeneration and repair of nerve tissue.
Materials and methods:
First, the total RNA was extracted from the hippocampus of rats at different stages of development. RT-PCR was used to detect the growth guiding factor GAP-43, Nogo-A, netrin-1, Sema 3A and Nrp-1 mRNA in the process of hippocampus development in rats, and the expression level of Rho pathway signal molecule Rho A. Rho kinase promoter LPA and inhibitor Y27632 were used to interfere with hippocampal neurons, LPA and Y27632 concentration 200ng/ml. The growth of cell protuberances was observed by atomic force microscopy, and the protuberances were extracted and quantified. Confocal microscopy was used to observe the rearrangement of cell microtubules and to observe subcellular localization and distribution characteristics of adherent egg white vinculin. The experiment further constructed the recombinant of the downstream signal CRMP-1 of the Rho kinase, and constructed the CRMP-1-phrGFP II -N eukaryotic expression vector by non directional cloning technique. The positive liposome method was transfected to NGF induced PC12 cells, and the effect of CRMP-1 on the growth of the cell protuberance was observed.
Result:
(1) expression of growth orientation factor and Rho pathway signaling molecule mRNA during hippocampus development in rats
During the development of rat hippocampus, the expression of growth factor GAP-43 mRNA embryo and new stage is more, the expression in young and adult stage is less (P < 0.05), the expression of old age is still high, Nogo-A is more expressed in the embryo stage, after birth and GAP-43, and at the peak period of adult and old age. The guide factor netrin-1 is born. The expression of rat, newborn rat and adult rat was the strongest. The expression of.Sema 3A in young and old age decreased gradually with the development of hippocampus, but the expression of its receptor Nrp-1 increased gradually from young to old. The expression of signal molecule Rho-A and Rac-1 was similar to the expression of Rho-A. With the development of hippocampus, the peak of expression was also obvious. In the embryo, the young and the old, the new stage and the adult stage are in the relatively low expression stage; the expression of Rac-1 is more than the expression of Rho-A,.CRMP-1 and tubulin at various stages of the development of the hippocampus. The expression of.CRMP-1 and the expression of the expression from the embryo to the adult is similar to the expression of the expression of the CRMP-1. There was more expression in rats, but the expression of CRMP-1 was significantly higher in the elderly stage than in the adult stage (P < 0.05), while tubulin remained at the adult stage in the elderly stage.
(2) Regulation of Rho kinase on neurite outgrowth and microtubule rearrangement in rat hippocampal neurons
Atomic force microscopy (AFM) showed that the number of neurites in the hippocampal neurons in the LPA treatment group decreased, some of the protuberances were only seen in the residual protuberance, and the number of the first to three protrusions decreased (P < 0.05). LPA was pretreated with Y27632, although the morphology of the cell body was not obviously changed, but the number of primary protuberances increased, showing radiation from the cell body. The number of the first and two stage protrusions increased (P < 0.05), the number of first and two protrusions was increased (P < 0.05). The cells after LPA treatment were lower than the control group (P < 0.05), and the cells in the Y27632 intervention group were higher than those in the LPA group (P < 0.05) after the pretreatment (P < 0.05), and there was no significant difference between the control group and the control group.
The confocal microscope showed that the cells of the hippocampal neurons, the protuberances and the growth cones all showed clear microtubules. The protuberances of the LPA intervention group were shorter, and the fluorescence of the protuberance was lighter. There was no clear visible microtubule in the cell, and the irregular microtubules were replaced with irregular arrangement and lost the original nests. The arrangement of microtubules in the protuberances appeared with braid changes and large gaps between the microtubules of the bundles; the growth cone lost the original appearance, only seen the fine ends and no typical growth cones. Most of the microtubules disappeared after the.LPA preconditioning, and Y27632 was used to intervene in the cells. More evenly, apart from the microtubules around the nucleus of the nucleus, the free microtubules of the end were visible, and the microtubules in the protuberances were not very regular, and the larger spaces between the microtubules were still visible, but they were arranged regularly in the LPA group. The clear microtubules are straight into the growth cone or bend and walk, the longer microtubules reach the central part of the growth cone, the short microtubules are scattered on the cell membrane at the root of the growth cone, and the green fluorescence points are scattered on the cell membrane on the cell membrane of the LPA intervention group; after LPA treatment, the cell membrane is interfered with the cell membrane. The dense green fluorescence is denser, and these fluorescent dots are often gathered together, denser in the surrounding area of the cell membrane and in the root of the protuberance, indicating that the vinculin protein is gathered around the cell membrane.
(3) construction of CRMP-1-phrGFP II -N eukaryotic expression vector and regulation of neurite outgrowth
The target gene fragment amplified from the total RNA of the rat hippocampus was 1800bp, conforming to the size of the design fragment. After the connection was transformed to form a white colony, the 1800bp size target gene fragment and the 3000bp size cloned carrier fragment appeared in the recombinant EcoR I after the single enzyme cut, and the unenzymed recombinant body was shown to 4800bp. bi-directional sequencing results, and CRMP-1 orders were shown. The gene fragment was 1746bp, and the sequence alignment with GenBank showed that only 4 base mutations did not affect the translation of protein. After the homology was connected to the expression vector, the homology was converted to bacteria, and the positive clones were picked up. The CRMP-1-phrGFP II -N recombinant strip was located at 6700bp, and the two fragments of 4900bp and 1800bp were displayed after the enzyme digestion.
After the induction of 50NG NGF, the protuberances of PCI2 cells were extended and differentiated into neuron like cells. The cells in the transfected group showed strong green fluorescence, and the fluorescence was distributed in the cell and the protuberance. The cell protuberance was long.CRMP-1-phrGFP II -N transfection group. The fluorescence of the cells was similar to the distribution of the empty body transfected group, mainly in the cell body and the protuberance, but the cell protruded more. In short, the cells expressing CRMP-1 rarely exceed the diameter of the cell body several times, and some longer protuberances are shorter than empty vectors.
Conclusion:
(1) during the development of hippocampus, the GAP-43 and Nogo-A in the embryonic stage were in high expression state, after birth, the GAP-43 remained high in the aged, while Nogo-A was highly expressed in both adult and old age, suggesting that the hippocampal neurons still have strong growth and regeneration ability in the aged and the high expression of inhibitory factors may be expressed. It's the reason why it's difficult to regenerate.
(2) the expression of growth guiding factor netrin-1 runs through the embryo, newborn, young and adult stage, and the expression of old age is low; and Sema 3A is mainly confined to the embryo and the newborn stage, but the expression of its receptor is gradually increasing after the low expression of the new stage.
(3) the development of Rho-A and Rac-1 signal molecules in cells has high expression at all stages, but it has obvious stages. The expression of new and adult stage is relatively low, and the embryo, young and old age are relatively high.
(4) the development of microtubulin is gradually decreasing from embryo to young age, and the development of adult and old age is relatively stable. The development of CRMP-1 is similar to the development of microtubules from embryo to adult stage, but the expression of old age is higher.
(5) activation of the Rho kinase pathway can induce the collapse of the neurite protuberance, the decrease of the number of protuberances at all levels and the shortening of the length. The inhibition of the Rho kinase pathway can promote the increase of the number of branches at all levels and the growth of the protuberance.Rho kinase not only by regulating the growth of the microtubule rearrangement and the protuberance, but also in the branching branching. Inhibition of Rho kinase activity can basically reverse the collapse of LPA to neurite growth, but it does not completely reverse LPA induced microtubule rearrangement.
(6) amplify the cDNA of CRMP-1, and complete the construction of CRMP-1-PGEM-T Easy cloning vector and CRMP-1-phrGFP II -N eukaryotic expression vector.
(7) after transfection of PC12 cells induced by NGF, CRMP-1 was expressed in cell body and protuberance, and the protuberances of PC12 cells introduced into CRMP-1 were obviously shortened, which showed that CRMP-1 had the effect of inhibiting the growth of protruding and inducing its collapse.
【學(xué)位授予單位】：南方醫(yī)科大學(xué)
【學(xué)位級別】：博士
【學(xué)位授予年份】：2007
【分類號】：R338

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孟瀟;原泉;宋楊;;Stathmin蛋白與乳腺癌的研究進(jìn)展[J];當(dāng)代醫(yī)學(xué);2011年25期

2 馮俊;李建軍;應(yīng)榮彪;吳云飛;徐惠綿;;βⅢ-微管蛋白在乳腺癌癌變不同階段的表達(dá)及意義[J];中華臨床醫(yī)師雜志(電子版);2011年08期

3 張群成;馬漢宸;邵楊;張棟;姜淑娟;;曲古抑菌素A聯(lián)合多西他賽對肺腺癌A549凋亡和α-tubulin蛋白的影響[J];山東大學(xué)學(xué)報(醫(yī)學(xué)版);2011年06期

4 吳利云;羅冬嬌;童夏生;阮正英;王恩智;陳豪;;葛根素對Rho激酶在大鼠心肌缺血-再灌注損傷中作用的影響[J];醫(yī)藥導(dǎo)報;2011年07期

5 陳培芬;羅雅玲;賴文巖;邢曉雯;駱子義;邱智輝;;巨噬細(xì)胞移動抑制因子經(jīng)Rho途徑促進(jìn)人肺成纖維細(xì)胞Ⅲ型膠原合成[J];中國病理生理雜志;2011年06期

6 鄭丹;梁躍進(jìn);毛雯倩;李冉;王勇;;鹽酸法舒地爾抗日本血吸蟲感染小鼠肝纖維化的作用[J];中國寄生蟲學(xué)與寄生蟲病雜志;2011年03期

7 樊英瑞;陸彬彬;楊春;王科明;;β_Ⅲ-tubulin在胃癌中的表達(dá)及臨床意義[J];臨床腫瘤學(xué)雜志;2011年07期

8 李通;田紅英;鄧艷;蘇達(dá)京;何寧宇;;鹽酸法舒地爾對腦梗死患者的療效及對血清中IL-1β、TNF-α和RHO激酶影響的觀察[J];海南醫(yī)學(xué)院學(xué)報;2011年08期

9 梁婧;徐立紅;;蛋白磷酸酶2A對微管的調(diào)控作用研究進(jìn)展[J];中國細(xì)胞生物學(xué)學(xué)報;2011年06期

10 鄭惠珍;趙靜;;大鼠骨髓間充質(zhì)干細(xì)胞分化的內(nèi)皮樣細(xì)胞促進(jìn)血管新生及Rho激酶的作用[J];生理學(xué)報;2011年04期

相關(guān)會議論文 前10條

1 畢朝位;周明國;陳長軍;王建新;;禾谷鐮孢菌兩個β-微管蛋白基因功能[A];中國植物病理學(xué)會2009年學(xué)術(shù)年會論文集[C];2009年

2 方唯碩;;通過調(diào)節(jié)與微管蛋白和P-糖蛋白的作用優(yōu)化紫杉醇類似物的抗癌活性[A];第七屆全國天然有機(jī)化學(xué)學(xué)術(shù)研討會論文集[C];2008年

3 張超;楊娜;楊春皓;丁華勝;羅成;張余;吳茂江;章雄文;沈旭;蔣華良;蒙凌華;丁健;;同時靶向PI3K/mTOR和微管的雙重抑制劑的S9抗腫瘤作用[A];2009醫(yī)學(xué)前沿論壇暨第十一屆全國腫瘤藥理與化療學(xué)術(shù)會議論文集[C];2009年

4 龔忠華;呂冰;梁建生;;玉米根尖細(xì)胞微管蛋白的免疫熒光定位及微管蛋白在細(xì)胞響應(yīng)滲透脅迫中的作用[A];長三角現(xiàn)代植物生物學(xué)與農(nóng)業(yè)專題論壇論文集[C];2005年

5 陳茂華;孫軍;陸川;陳獻(xiàn)東;蔡建勇;巴華君;林建虎;何學(xué)雄;;蛛網(wǎng)膜下腔出血后RHO激酶對腦血管痙攣的調(diào)控研究[A];2009年浙江省神經(jīng)外科學(xué)術(shù)年會論文匯編[C];2009年

6 王建鋒;呂華鷹;黃耀堅;鄭忠輝;蘇文金;;一株紅豆杉內(nèi)生真菌產(chǎn)生的紫杉醇類似物[A];第四屆中國新醫(yī)藥博士論壇論文集[C];1999年

7 賈曉明;蔡宏;馬彩虹;吳志谷;姚詠明;楊毅;李紹然;陸江陽;;低溫冷凍對皮膚α-tubulin、β-tubulin和cytoskeratin表達(dá)的影響[A];第四屆全國燒傷救治專題研討會燒傷感染救治新進(jìn)展論文匯編[C];2006年

8 韓俊;張瑾;姚海蘭;王小凡;李鋒;陳嵐;高晨;高建梅;聶凱;董小平;;微管相關(guān)蛋白Tau與朊蛋白PrP的相互作用的研究[A];第一屆全國腦與認(rèn)知科學(xué)學(xué)術(shù)研討會論文集[C];2005年

9 韓曉濱;陳學(xué)存;張文治;李蘭英;陳琢聿;龐智玲;;�；撬釋θ四X神經(jīng)細(xì)胞微管蛋白的發(fā)育及14—3—2蛋白表達(dá)的影響[A];北京食品學(xué)會青年科技論文集[C];1992年

10 張能芳;;以微管為靶標(biāo)的抗腫瘤藥物研究進(jìn)展(影響微管力學(xué)的藥物)[A];腫瘤藥物及腫瘤傳統(tǒng)醫(yī)學(xué)治療研究[C];2005年

相關(guān)重要報紙文章 前10條

1 劉亦飛;美癌癥研究學(xué)會年會聚焦新藥前沿研究[N];中國醫(yī)藥報;2007年

2 記者 韋忠南　通訊員 涂建成;一位在美湖北人的科學(xué)路[N];湖北日報;2011年

3 金利;為研發(fā)新型抗腫瘤藥物奠定基礎(chǔ)[N];科技日報;2006年

4 記者　王華鋒;應(yīng)多從天然藥物中尋找抗癌藥[N];中國醫(yī)藥報;2006年

5 程書權(quán);中藥系列活性成分治療肝病的現(xiàn)代研究[N];中國中醫(yī)藥報;2004年

6 張驍；束梅英;抗腫瘤新靶點(diǎn)研究[N];中國醫(yī)藥報;2004年

7 喬貴賓邋吳一龍;“辯基因論治”——腫瘤個體化治療的新手段[N];醫(yī)藥經(jīng)濟(jì)報;2007年

8 馮紅云;警惕化療藥物的神經(jīng)毒性作用[N];中國醫(yī)藥報;2008年

9 記者 何屹;英利用轉(zhuǎn)基因蚊子防治瘧疾[N];科技日報;2005年

10 ;美研究員意外發(fā)現(xiàn)癌癥新療法[N];福建科技報;2007年

相關(guān)博士學(xué)位論文 前10條

1 郭國慶;Rho激酶通路對大鼠海馬神經(jīng)元突起生長和微管重排的調(diào)節(jié)[D];南方醫(yī)科大學(xué);2007年

2 尹云厚;中藥復(fù)方制劑對缺氧大鼠微管蛋白和驅(qū)動蛋白表達(dá)影響的研究[D];中國人民解放軍軍需大學(xué);2003年

3 楊大海;卡鉑損傷灰鼠耳蝸內(nèi)毛細(xì)胞對其耳蝸核神經(jīng)元的影響[D];中國協(xié)和醫(yī)科大學(xué);2004年

4 苗志林;Rho激酶在炎癥因子誘導(dǎo)的小型豬冠狀動脈狹窄病變的表達(dá)及雷帕霉素干預(yù)的研究[D];中國醫(yī)科大學(xué);2005年

5 沈雪莉;新生大鼠皮層神經(jīng)干細(xì)胞定向分化為神經(jīng)元過程中溶酶體與微管蛋白的相關(guān)性研究[D];中國醫(yī)科大學(xué);2004年

6 關(guān)啟剛;炎癥因子介導(dǎo)的小型豬冠狀動脈痙攣Rho激酶的作用機(jī)制與通心絡(luò)干預(yù)研究[D];中國醫(yī)科大學(xué);2006年

7 楊莉;Rho激酶在低氧大鼠肺小動脈的表達(dá)及燈盞花素預(yù)防作用的研究[D];四川大學(xué);2006年

8 王躍明;N-（2，6-二甲氧基吡啶-3-取代）-9-甲基咔唑-3-磺酰胺（IG-105）作為全新小分子微管蛋白配體藥物的抗腫瘤作用，特點(diǎn)及分子機(jī)制[D];中國協(xié)和醫(yī)科大學(xué);2008年

9 鄺勇;缺氧早期心肌細(xì)胞微管損傷與線粒體損害的關(guān)系研究[D];第三軍醫(yī)大學(xué);2007年

10 鄒根;球孢白僵菌對苯并咪唑類殺菌劑抗性的分子機(jī)理及遺傳改良[D];浙江大學(xué);2008年

相關(guān)碩士學(xué)位論文 前10條

1 王廣菲;非受體酪氨酸激酶c-Abl調(diào)節(jié)微管組裝的機(jī)理研究[D];安徽大學(xué);2010年

2 張海燕;家蠶微孢子蟲（浙江）α、β微管蛋白部分基因的克隆及系統(tǒng)發(fā)育分析[D];西北農(nóng)林科技大學(xué);2007年

3 姚楊;三角渦蟲β微管蛋白和Rab蛋白cDNA文庫的克隆及生物信息學(xué)分析[D];陜西師范大學(xué);2010年

4 裴麗麗;巨噬細(xì)胞移動抑制因子在動脈粥樣硬化中的作用及機(jī)制[D];吉林大學(xué);2009年

5 何紅波;Alzheimer病患者血漿β—微管蛋白和淀粉樣蛋白前體變化的研究[D];暨南大學(xué);2003年

6 查彩慧;Alzheimer病患者皮膚基底細(xì)胞微管、微管蛋白與tau蛋白的研究[D];暨南大學(xué);2002年

7 范妮;Alzheimer病患者血小板微管、微管蛋白與tau蛋白的研究[D];暨南大學(xué);2003年

8 皇甫蓓蓓;Rho/Rho激酶信號通路在實驗性變態(tài)反應(yīng)性腦脊髓炎發(fā)生機(jī)制中的作用研究[D];泰山醫(yī)學(xué)院;2009年

9 賈卓敏;Rho激酶與大鼠逼尿肌不穩(wěn)定的關(guān)系研究[D];第三軍醫(yī)大學(xué);2005年

10 翟志永;強(qiáng)制性運(yùn)動療法對大鼠腦缺血再灌注后神經(jīng)修復(fù)及Rho激酶表達(dá)的影響[D];中國醫(yī)科大學(xué);2008年

，

本文編號：2078268